Breast cancer is now understood to be a complex and heterogeneous disease4, categorized into various subtypes based on the expression levels of human epidermal growth factor receptor 2 (HER-2), progesterone receptor (PR), and estrogen receptor (ER)5. This evidence concerns the gene ERBB2 and breast cancer.